Rapid Kidney Function Decline in Older Adults
Identification of Rapid Kidney Function Decline in Older Adults with Different Types of Aging
1 other identifier
observational
1,539
1 country
1
Brief Summary
This observational study investigates whether a single set of GFR and urine albumin-to-creatinine ratio (ACR) thresholds can accurately screen for rapid kidney function decline in different elderly groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2022
CompletedFirst Submitted
Initial submission to the registry
January 5, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2025
CompletedJanuary 9, 2025
July 1, 2024
11.5 years
January 5, 2025
January 5, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
A ≥30% decline in glomerular filtration rate (GFR) within 2 years, i.e. a rapid decline in renal function
The risk of rapid decline in kidney function in the elderly was assessed during a 2-year follow-up period
Study Arms (2)
Rugao Longevity and Aging Study (RLAS) cohort
A total of 1,236 older adults from the Rugao Longevity and Aging Study (RLAS) were enrolled in the study, including 575 healthy aging individuals and 661 with comorbid co-morbidities (e.g., diabetes mellitus, hypertension, coronary heart disease, etc.). The objective of the study was twofold: first, to assess the predictive value of baseline glomerular filtration rate (GFR) to urinary albumin-creatinine ratio (ACR) for rapid decline in renal function (≥30% decline in GFR) within 2 years; and second, to establish early warning criteria for different types of aging populations.
Healthcare data from Huashan Hospital, Fudan University (CKD)
The present cohort comprised 303 elderly patients suffering from chronic kidney disease (CKD) from Huashan Hospital of Fudan University, including cases progressing from acute kidney injury (AKI) to CKD. The objective of the study was twofold: first, to assess the predictive ability of baseline GFR and ACR levels for rapid decline in renal function (≥30% GFR) within two years; and second, to establish appropriate early risk assessment criteria for the elderly CKD population.
Eligibility Criteria
kidney disease patient
You may qualify if:
- Age greater than 70 years;
- GFR data measured at least twice (two years apart) and ACR data measured once (at baseline);
- A clear record of the cause of the previous visit; from this, people diagnosed with kidney disease were selected, and kidney disease was defined as various primary nephritis, secondary nephropathy, acute kidney injury (AKI), chronic kidney disease, kidney tumors, or a diagnosis of proteinuria alone.
- Signed informed consent form.
You may not qualify if:
- People with missing baseline biochemical data;
- Outliers in the population indicators, i.e., data deviating from the mean ± three times the standard deviation;
- Data with significantly abnormal baseline renal function follow-up (abnormally elevated GFR by more than 10% within 2 years or abnormal ACR value as determined by consultation with a senior nephrologist).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Huashan Hospitallead
Study Sites (1)
Huashan hospital, Fudan university
Shanghai, Shanghai Municipality, 200040, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jing Chen, PhD, MD
Huashan Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 5, 2025
First Posted
January 9, 2025
Study Start
July 1, 2011
Primary Completion
December 25, 2022
Study Completion
December 25, 2022
Last Updated
January 9, 2025
Record last verified: 2024-07